# BT Brands, Inc.: financial statements, quarterly

BTBD · Nasdaq · CIK 1718224 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/btbd.md) · [Financials](/companies/btbd/financials.md) · [Filings](/companies/btbd/filings.md) · [Insiders](/companies/btbd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/btbd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-07-02) | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-29) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [4,000](/filings/0001477932-24-004919.md) | [4,008](/filings/0001477932-24-007110.md) | [2,998 d](/filings/0001477932-25-002248.md) | [3,190](/filings/0001477932-25-003689.md) | [4,111](/filings/0001477932-25-006037.md) | [4,349](/filings/0001477932-25-008407.md) | [3,174 d](/filings/0001477932-25-002248.md) | [3,231](/filings/0001477932-26-003265.md) | [3,780](/filings/0001477932-26-005132.md) | [3,854](/filings/0001477932-25-008407.md) | [2,844](/filings/0001477932-26-003265.md) | [3,551](/filings/0001477932-26-005132.md) |
| Operating income | $k | [(79.5)](/filings/0001477932-24-004919.md) | [40.6](/filings/0001477932-24-007110.md) | [(783) d](/filings/0001477932-25-002248.md) | [(631)](/filings/0001477932-25-003689.md) | [(189)](/filings/0001477932-25-006037.md) | [(75.0)](/filings/0001477932-25-008407.md) | [(938) d](/filings/0001477932-25-002248.md) | [(292)](/filings/0001477932-26-003265.md) | [(75.1)](/filings/0001477932-26-005132.md) | [735](/filings/0001477932-25-008407.md) | [(233)](/filings/0001477932-26-003265.md) | [117](/filings/0001477932-26-005132.md) |
| Interest expense | $k | [24.4](/filings/0001477932-24-004919.md) | [23.9](/filings/0001477932-24-007110.md) | [23.8 d](/filings/0001477932-25-002248.md) | [27.5](/filings/0001477932-25-003689.md) | [22.6](/filings/0001477932-25-006037.md) | [22.6](/filings/0001477932-25-008407.md) | [27.3 d](/filings/0001477932-25-002248.md) | [21.6](/filings/0001477932-26-003265.md) | [19.6](/filings/0001477932-26-005132.md) | [16.4](/filings/0001477932-25-008407.md) | [21.4](/filings/0001477932-26-003265.md) | [19.0](/filings/0001477932-26-005132.md) |
| Income tax | $k | [(52.0)](/filings/0001477932-24-004919.md) | [0.0](/filings/0001477932-24-007110.md) | [(63.0) d](/filings/0001477932-25-002248.md) | [(118)](/filings/0001477932-25-003689.md) | [12.5](/filings/0001477932-25-006037.md) | [(14.0)](/filings/0001477932-25-008407.md) | [350 d](/filings/0001477932-25-002248.md) | [0.0](/filings/0001477932-26-003265.md) | [0.0](/filings/0001477932-26-005132.md) | [0.0](/filings/0001477932-25-008407.md) | [0.0](/filings/0001477932-26-003265.md) | [0.0](/filings/0001477932-26-005132.md) |
| Net income | $k | [(234)](/filings/0001477932-24-004919.md) | [(3.5)](/filings/0001477932-24-007110.md) | [(508) d](/filings/0001477932-25-002248.md) | [446](/filings/0001477932-25-003689.md) | [(70.0)](/filings/0001477932-25-006037.md) | [(219)](/filings/0001477932-25-008407.md) | [(1,576) d](/filings/0001477932-25-002248.md) | [(330)](/filings/0001477932-26-003265.md) | [55.0](/filings/0001477932-26-005132.md) | [915](/filings/0001477932-25-008407.md) | [(751)](/filings/0001477932-26-003265.md) | [576](/filings/0001477932-26-005132.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | [(0.04)](/filings/0001477932-25-008407.md) | not reported | [(0.05)](/filings/0001477932-26-003265.md) | [0.01](/filings/0001477932-26-005132.md) | [0.15](/filings/0001477932-25-008407.md) | [(0.12)](/filings/0001477932-26-003265.md) | [0.09](/filings/0001477932-26-005132.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | [(0.04)](/filings/0001477932-25-008407.md) | not reported | not reported | [0.01](/filings/0001477932-26-005132.md) | [0.15](/filings/0001477932-25-008407.md) | not reported | [0.09](/filings/0001477932-26-005132.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-01) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | period not labelled (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [7.5](/filings/0001477932-23-008521.md) | [7.2](/filings/0001477932-25-002248.md) | [6.7](/filings/0001477932-24-002958.md) | [5.9](/filings/0001477932-24-004919.md) | [5.7](/filings/0001477932-24-007110.md) | [5.1](/filings/0001477932-25-008407.md) | [4.5](/filings/0001477932-25-003689.md) | [5.6](/filings/0001477932-25-006037.md) | [6.6](/filings/0001477932-25-008407.md) | [5.9](/filings/0001477932-26-005132.md) | [5.2](/filings/0001477932-26-003265.md) | [5.8](/filings/0001477932-26-005132.md) |
| Total assets | $m | [14.9](/filings/0001477932-23-008521.md) | [14.6](/filings/0001477932-25-002248.md) | [14.0](/filings/0001477932-24-002958.md) | [14.0](/filings/0001477932-24-004919.md) | [13.7](/filings/0001477932-24-007110.md) | [12.0](/filings/0001477932-25-008407.md) | [11.0](/filings/0001477932-25-003689.md) | [11.2](/filings/0001477932-25-006037.md) | [11.9](/filings/0001477932-25-008407.md) | [10.7](/filings/0001477932-26-005132.md) | [10.0](/filings/0001477932-26-003265.md) | [10.5](/filings/0001477932-26-005132.md) |
| Current liabilities | $m | [1.3](/filings/0001477932-23-008521.md) | [1.6](/filings/0001477932-25-002248.md) | [1.4](/filings/0001477932-24-002958.md) | [1.5](/filings/0001477932-24-004919.md) | [1.5](/filings/0001477932-24-007110.md) | [1.4](/filings/0001477932-25-008407.md) | [1.0](/filings/0001477932-25-003689.md) | [1.2](/filings/0001477932-25-006037.md) | [1.0](/filings/0001477932-25-008407.md) | [1.2](/filings/0001477932-26-005132.md) | [1.3](/filings/0001477932-26-003265.md) | [1.3](/filings/0001477932-26-005132.md) |
| Total liabilities | $m | [5.3](/filings/0001477932-23-008521.md) | [5.4](/filings/0001477932-25-002248.md) | [5.2](/filings/0001477932-24-002958.md) | [5.3](/filings/0001477932-24-004919.md) | [5.2](/filings/0001477932-24-007110.md) | [5.0](/filings/0001477932-25-008407.md) | [4.3](/filings/0001477932-25-003689.md) | [4.4](/filings/0001477932-25-006037.md) | [4.2](/filings/0001477932-25-008407.md) | [4.3](/filings/0001477932-26-005132.md) | [4.3](/filings/0001477932-26-003265.md) | [4.1](/filings/0001477932-26-005132.md) |
| Long-term debt | $m | [2.3](/filings/0001477932-23-008521.md) | [2.3](/filings/0001477932-25-002248.md) | [2.2](/filings/0001477932-24-002958.md) | [2.2](/filings/0001477932-24-004919.md) | [2.2](/filings/0001477932-24-007110.md) | [2.1](/filings/0001477932-25-008407.md) | [2.1](/filings/0001477932-25-003689.md) | [2.0](/filings/0001477932-25-006037.md) | [1.9](/filings/0001477932-25-008407.md) | [1.9](/filings/0001477932-26-005132.md) | [1.8](/filings/0001477932-26-003265.md) | [1.8](/filings/0001477932-26-005132.md) |
| Current portion of debt | $m | [0.2](/filings/0001477932-23-008521.md) | [0.2](/filings/0001477932-25-002248.md) | [0.2](/filings/0001477932-24-002958.md) | [0.2](/filings/0001477932-24-004919.md) | [0.2](/filings/0001477932-24-007110.md) | [0.2](/filings/0001477932-25-008407.md) | [0.2](/filings/0001477932-25-003689.md) | [0.2](/filings/0001477932-25-006037.md) | [0.2](/filings/0001477932-25-008407.md) | [0.2](/filings/0001477932-26-005132.md) | [0.2](/filings/0001477932-26-003265.md) | [0.2](/filings/0001477932-26-005132.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | [0.1](/filings/0001477932-24-007110.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [9.6](/filings/0001477932-24-007110.md) | [9.2](/filings/0001477932-25-008407.md) | [8.8](/filings/0001477932-25-006037.md) | [8.7](/filings/0001477932-25-008407.md) | [8.5](/filings/0001477932-25-008407.md) | [7.0](/filings/0001477932-26-005132.md) | [6.7](/filings/0001477932-26-005132.md) | [6.8](/filings/0001477932-26-005132.md) | [7.7](/filings/0001477932-25-008407.md) | [6.4](/filings/0001477932-26-005132.md) | [5.7](/filings/0001477932-26-005132.md) | [6.3](/filings/0001477932-26-005132.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-07-02) | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [363 d](/filings/0001477932-24-004919.md) | [37.0 d](/filings/0001477932-24-007110.md) | [(184) d](/filings/0001477932-25-002248.md) | [(409)](/filings/0001477932-25-003689.md) | [82.5 d](/filings/0001477932-25-006037.md) | [129 d](/filings/0001477932-25-008407.md) | [(526) d](/filings/0001477932-25-002248.md) | [(307)](/filings/0001477932-26-003265.md) | [384 d](/filings/0001477932-26-005132.md) | [325 d](/filings/0001477932-25-008407.md) | [(97.7)](/filings/0001477932-26-003265.md) | [215 d](/filings/0001477932-26-005132.md) |
| Capital expenditure | $k | [159 d](/filings/0001477932-24-004919.md) | [96.5 d](/filings/0001477932-24-007110.md) | [126 d](/filings/0001477932-25-002248.md) | [112](/filings/0001477932-25-003689.md) | [28.8 d](/filings/0001477932-25-006037.md) | [78.8 d](/filings/0001477932-25-008407.md) | [274 d](/filings/0001477932-25-002248.md) | [124](/filings/0001477932-26-003265.md) | [0.0 d](/filings/0001477932-26-005132.md) | [63.4 d](/filings/0001477932-25-008407.md) | [40.1](/filings/0001477932-26-003265.md) | [52.9 d](/filings/0001477932-26-005132.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [6,182](/filings/0001477932-25-008407.md) | [6,155](/filings/0001477932-26-003265.md) | [6,160](/filings/0001477932-25-008407.md) | [6,155](/filings/0001477932-26-003265.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,184,724 at 2026-08-17, from the cover of the [10-Q filed 2026-08-17](/filings/0001477932-26-005132.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.